Chubb Group of Insurance Companies Releases New Online Insurance System
A new online system from the Chubb Group of Insurance Companies aims to help life sciences companies obtain clinical trial liability insurance documentation more quickly and easily. The new system, Chubb WORLDcert, allows drug and medical device developers to secure required insurance documentation for clinical trials around the globe.
Life science companies and contract research organizations can find it difficult to secure approval from a medical institution’s ethics committee to begin a clinical trial without accurate documentation that appropriate insurance has been secured.
WORLDcert provides instant certificates of insurance in 149 countries. Sponsors of clinical trials in these countries generally will be able to receive certificates without having to wait for an insurance agent or broker.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
